# To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers

> **NCT02690727** · PHASE1 · COMPLETED · sponsor: **Rhizen Pharmaceuticals SA** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** RP6530

## Key facts

- **NCT ID:** NCT02690727
- **Lead sponsor:** Rhizen Pharmaceuticals SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02690727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02690727, "To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02690727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*